Literature DB >> 9083514

Immunohistochemical localization of acidic fibroblast growth factor in normal human enterochromaffin cells and related gastrointestinal tumours.

S La Rosa1, A M Chiaravalli, C Capella, S Uccella, F Sessa.   

Abstract

Acidic fibroblast growth factor (aFGF) is a member of the structurally related heparin-binding growth factor family. The best studied members of this family are aFGF and basic FGF (bFGF), which are potent mitogens and differentiation factors for mesoderm-derived cells, including fibroblasts. This study was designed to verify the immunohistochemical expression of aFGF in normal human endocrine cells of the gut and in related endocrine tumours. We examined normal gastrointestinal mucosa from seven different subjects and 41 gut endocrine tumours from different sites, including stomach, duodenum, and small and large intestine, using an aFGF polyclonal antibody with no cross-reactivity for bFGF. We localized aFGF in a fraction of serotonin-producing enterochromaffin (EC) cells of the normal gut, while it was absent in gastrin (G), CCK, secretion (S), somatostatin (D) and glicentin (L) cells. aFGF immunoreactivity was also expressed in serotonin producing EC cell tumours, but not in other functional types of gut endocrine neoplasms investigated, including gastric ECL cell, duodenal somatostatin and gastrin cell, and rectal L cell tumours. A positive correlation was found between expression of aFGF and the amount of tumour fibrous stroma, suggesting that aFGF may be involved in proliferation and activity of stromal fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083514     DOI: 10.1007/bf01008032

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  47 in total

Review 1.  Modes of FGF release in vivo and in vitro.

Authors:  P A D'Amore
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

2.  The genes for basic and acidic fibroblast growth factors are on different human chromosomes.

Authors:  A Mergia; R Eddy; J A Abraham; J C Fiddes; T B Shows
Journal:  Biochem Biophys Res Commun       Date:  1986-07-31       Impact factor: 3.575

3.  Chromogranin: a newly recognized marker for endocrine cells of the human gastrointestinal tract.

Authors:  P Facer; A E Bishop; R V Lloyd; B S Wilson; R J Hennessy; J M Polak
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens.

Authors:  H Y Lan; W Mu; D J Nikolic-Paterson; R C Atkins
Journal:  J Histochem Cytochem       Date:  1995-01       Impact factor: 2.479

Review 6.  Growth factors and carcinoid tumours.

Authors:  O Nilsson; B Wängberg; A McRae; A Dahlström; H Ahlman
Journal:  Acta Oncol       Date:  1993       Impact factor: 4.089

7.  Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography.

Authors:  R R Lobb; J W Fett
Journal:  Biochemistry       Date:  1984-12-18       Impact factor: 3.162

8.  Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma (SCC).

Authors:  Y Myoken; Y Myoken; T Okamoto; J D Sato; K Takada
Journal:  J Oral Pathol Med       Date:  1994-11       Impact factor: 4.253

9.  Fibroblast growth factor phosphorylation and receptors in rod outer segments.

Authors:  F Mascarelli; D Raulais; Y Courtois
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

10.  Expression of fibroblast growth factor 1 is lower in breast cancer than in the normal human breast.

Authors:  G S Bansal; C Yiangou; R C Coope; J J Gomm; Y A Luqmani; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

View more
  10 in total

1.  Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas.

Authors:  S La Rosa; F Sessa; L Colombo; M G Tibiletti; D Furlan; C Capella
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Abdominal angina in patients with a midgut carcinoid, a sign of severe pathology.

Authors:  Harry deVries; Rob T M Wijffels; Pax H B Willemse; René C J Verschueren; Ido P Kema; Arend Karrenbeld; Ted R Prins; Elisabeth G E deVries
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

Review 3.  Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity.

Authors:  J J Worthington; F Reimann; F M Gribble
Journal:  Mucosal Immunol       Date:  2017-08-30       Impact factor: 7.313

4.  Small intestinal ulceration secondary to carcinoid tumour arising in a Meckel's diverticulum.

Authors:  W G McCluggage; L McConnell; J M Sloan; P K Ellis; S T Irwin
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

Review 5.  Pathophysiology of Gastric NETs: Role of Gastrin and Menin.

Authors:  Sinju Sundaresan; Anthony J Kang; Juanita L Merchant
Journal:  Curr Gastroenterol Rep       Date:  2017-07

Review 6.  Medical treatment for gastro-entero-pancreatic neuroendocrine tumours.

Authors:  Rossana Berardi; Francesca Morgese; Mariangela Torniai; Agnese Savini; Stefano Partelli; Silvia Rinaldi; Miriam Caramanti; Consuelo Ferrini; Massimo Falconi; Stefano Cascinu
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

Review 7.  What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?

Authors:  Gowri M Ratnayake; Faidon-Marios Laskaratos; Dalvinder Mandair; Martyn E Caplin; Krista Rombouts; Christos Toumpanakis
Journal:  Curr Oncol Rep       Date:  2022-05-13       Impact factor: 5.945

8.  Localization of Hepatocyte Growth Factor and Its Receptor met in Endocrine Cells and Related Tumors of the Gut and Pancreas: An Immunohistochemical Study.

Authors:  Stefano La Rosa; Silvia Uccella; Carlo Capella; Silvia Erba; Fausto Sessa
Journal:  Endocr Pathol       Date:  2000       Impact factor: 4.056

Review 9.  PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franziska Briest; Patricia Grabowski
Journal:  Theranostics       Date:  2014-01-29       Impact factor: 11.556

Review 10.  Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications.

Authors:  Giovanni Vitale; Alessia Cozzolino; Pasqualino Malandrino; Roberto Minotta; Giulia Puliani; Davide Saronni; Antongiulio Faggiano; Annamaria Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-14       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.